Vascular pythiosis in a thalassemic patient

Kamphol Laohapensang1, Robert B Rutherford, Jitwadee Supabandhu

  • 1Department of Surgery, Chiang Mai University Hoospital, Chiang Mai, Thailand. Klaohape@mail.med.cmu.ac.th

Vascular
|August 25, 2009
PubMed

Insights

Pythium insidiosum, a fungus, causes emerging pythiosis in humans, particularly those with thalassemia. Diagnosis via histopathology and immunoblotting is crucial for effective treatment, as systemic therapies often fail.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Vascular Surgery

Background:

  • Pythium insidiosum causes pythiosis, an emerging infectious disease affecting both animals and humans globally.
  • Human pythiosis presents in localized and systemic/vascular forms, frequently associated with hemoglobinopathies like thalassemia.

Observation:

  • A case of a thalassemic horse stable worker with ulcerative cutaneous pythiosis progressing to necrotizing arteritis and aneurysm formation in the lower leg.
  • Initial diagnosis was challenging, with P. insidiosum not isolated by culture but confirmed via histopathology and immunoblotting.

Findings:

  • Histopathology and immunoblotting proved essential for diagnosing P. insidiosum infection, aiding critical preoperative decisions.
  • Standard systemic antibiotics and antimycotics showed limited efficacy against systemic pythiosis.

Implications:

  • Radical surgical debridement is currently the primary life-saving intervention for systemic pythiosis.
  • Immunotherapy, successful in animal cases, holds potential as a beneficial treatment for human vascular pythiosis.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...